STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

FDA adcomm backs Grail’s cancer blood test, Gilead betting on autoimmune drug data, and more biotech news Courtesy Tslil Ast Mootha Laboratory Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The full A24 trailer about the new Elizabeth Holmes documentary dropped yesterday, as did a single glassy tear from the Theranos founder’s eye. “It took me a really long time to be okay with.… letting someone see me cry,” she says. And speaking of Holmes, she be be leaving prison early. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Original Source

Read the full article at Statnews →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.